USES AND COMPOSITIONS FOR TREATMENT OF PSORIASIS AND CROHN'S DISEASE
    4.
    发明申请
    USES AND COMPOSITIONS FOR TREATMENT OF PSORIASIS AND CROHN'S DISEASE 审中-公开
    用于治疗PSORIASIS和CROHN病的用途和组合物

    公开(公告)号:US20120282262A1

    公开(公告)日:2012-11-08

    申请号:US13346215

    申请日:2012-01-09

    IPC分类号: G06F19/24 A61P1/00 A61K39/395

    CPC分类号: C07K16/241 A61K2039/505

    摘要: The invention provides methods, uses and compositions for the treatment of psoriasis or Crohn's disease. The invention describes methods and uses for treating psoriasis or Crohn's disease, wherein a TNFα inhibitor, such as a human TNFα antibody, or antigen-binding portion thereof, is used to treat psoriasis in a subject. The invention includes methods of improving patient reported outcomes using a human human TNFα antibody, or antigen-binding portion thereof, for the treatment of Crohn's or psoriasis. The invention also provides methods of improving fatigue or depression in patients having Crohns'.

    摘要翻译: 本发明提供了用于治疗牛皮癣或克罗恩病的方法,用途和组合物。 本发明描述了用于治疗牛皮癣或克罗恩病的方法和用途,其中使用TNFα抑制剂,例如人TNFα抗体或其抗原结合部分来治疗受试者的牛皮癣。 本发明包括使用人类人TNFα抗体或其抗原结合部分改善患者报告结果的方法,用于治疗克罗恩病或牛皮癣。 本发明还提供了改善患有克罗恩病患者的疲劳或抑郁症的方法。

    METHODS AND COMPOSITIONS FOR TREATMENT OF SKIN DISORDERS
    5.
    发明申请
    METHODS AND COMPOSITIONS FOR TREATMENT OF SKIN DISORDERS 有权
    用于治疗皮肤疾病的方法和组合物

    公开(公告)号:US20110171227A1

    公开(公告)日:2011-07-14

    申请号:US12859181

    申请日:2010-08-18

    摘要: The invention provides methods and compositions for the treatment of a skin disorder associated with detrimental TNFα activity, such as psoriasis. The invention includes methods for treating a skin disorder associated with detrimental TNFα activity, such as psoriasis, in a subject who has failed or lost response to prior biologic therapy, such as prior administration of etanercept. The invention further provides methods for determining the efficacy of a human TNFα antibody, or antigen-binding portion thereof, for the treatment of a skin disorder associated with detrimental TNFα activity, such as psoriasis.

    摘要翻译: 本发明提供了治疗与有害的TNFα活性相关的皮肤病症如牛皮癣的方法和组合物。 本发明包括治疗与先前生物治疗失败或失去应答的受试者(例如先前给予依那西普)有关的TNFα活性相关的皮肤病症如牛皮癣的方法。 本发明还提供了用于确定人TNFα抗体或其抗原结合部分用于治疗与有害的TNFα活性如牛皮癣相关的皮肤病症的功效的方法。